Infliximab (anti-TNF-alpha) [170277-31-3]
A2019
Product group Chemicals
Overview
- SupplierSelleck Chemicals
- Product NameInfliximab (anti-TNF-alpha) [170277-31-3]
- Delivery Days Customer9
- CertificationResearch Use Only
- Scientific DescriptionInfliximab (anti-TNF-alpha) (Remicade, Remsima, Inflectra) is a purified, recombinant DNA-derived chimeric human-mouse IgG monoclonal antibody that consists of mouse heavy and light chain variable regions combined with human heavy and light chain constant regions. Infliximab neutralizes the biological activity of TNF-alfa by binding with high affinity to the soluble and transmembrane forms of TNF-alfa, and inhibits or prevents the effective binding of TNF-alfa with its receptors. MW=144.2 kDa.
- UNSPSC12352200